Abstract: A conveyor system includes a conveyor having an endless loop flexible member and a plurality of inserts. The conveyor system additionally includes a drive shaft and a sprocket coupled to the drive shaft. The sprocket includes a hub and a plurality of teeth extending radially outward from the hub, where at least one tooth is substantially planar and defines a channel having a plate disposed within the channel. The sprocket also includes a sprocket tooth cap fixedly coupled via an interference fit to the tooth and the plate. The sprocket tooth cap includes a first end defining a channel and an engagement face configured to drivingly engage the endless loop flexible member, and a second end defining a cavity. The cavity defining a pair of opposite facing surfaces, where the pair of opposite facing surfaces is configured to form the interference fit with the at least one tooth.

Abstract: A conveyor system includes a conveyor having an endless loop flexible member and a plurality of inserts. The conveyor system additionally includes a drive shaft and a sprocket coupled to the drive shaft. The sprocket includes a hub and a plurality of teeth extending radially outward from the hub, where at least one tooth is substantially planar and defines a channel having a plate disposed within the channel. The sprocket also includes a sprocket tooth cap fixedly coupled via an interference fit to the tooth and the plate. The sprocket tooth cap includes a first end defining a channel and an engagement face configured to drivingly engage the endless loop flexible member, and a second end defining a cavity. The cavity defining a pair of opposite facing surfaces, where the pair of opposite facing surfaces is configured to form the interference fit with the at least one tooth.

Abstract: A temperature regulating device for a user's neck includes a housing that extends about the neck and has a base portion, and first and second side portions. The side portions each have an air duct extending from an air inlet to an air outlet in communication with air inlets of an air duct within the base portion. Two thermoelectric are devices located within each of the side portions. Each thermoelectric device is in thermal connection with a cold space member at exterior sides of the side portions for contacting the lateral sides of the neck. Two fans within the base portion are configured to pull air through the side portions past the thermoelectric devices to the base portion and out through the air outlets of the base portion. Only the side portions of the housing selectively heat and cool the neck near pulse points of the neck.

Abstract: A temperature regulating device for a user's neck includes a housing that extends about the neck and has a base portion, and first and second side portions. The side portions each have an air duct extending from an air inlet to an air outlet in communication with air inlets of an air duct within the base portion. Two thermoelectric are devices located within each of the side portions. Each thermoelectric device is in thermal connection with a cold space member at exterior sides of the side portions for contacting the lateral sides of the neck. Two fans within the base portion are configured to pull air through the side portions past the thermoelectric devices to the base portion and out through the air outlets of the base portion. Only the side portions of the housing selectively heat and cool the neck near pulse points of the neck.

Abstract: A utility ramp having a latching feature to attach the utility ramp to steps mounted on the side of a vehicle. The latching feature provides a means for securing the utility ramp to the steps and allows the utility ramp to be used as a vehicle running board. Further, the utility ramp may include one or more jointed segments to allow the utility ramp to approximate a curved ramp.

Abstract: CDR-grafted antibody heavy and light chains comprise acceptor framework and donor antigen binding regions, the heavy chains comprising donor residues at at least one of positions (6, 23) and/or (24, 48) and/or (49, 71) and/or (73, 75) and/or (76) and/or (78) and (88) and/or (91). The CDR-grafted light chains comprise donor residues at at least one of positions (1) and/or (3) and (46) and/or (47) or at at least one of positions (46, 48, 58) and (71). The CDR-grafted antibodies are preferably humanised antibodies, having non human, e.g. rodent, donor and human acceptor frameworks, and may be used for in vivo therapy and diagnosis. A generally applicable protocol is disclosed for obtaining CDR-grafted antibodies.

Abstract: CDR-grafted antibody heavy and light chain comprise acceptor framework and donor antigen binding regions, the heavy chains comprising donor residues at at least one of positions (6, 23) and/or (24, 48) and/or (49, 71) and/or (73, 75) and/or (76) and/or (78) and (88) and/or (91). The CDR-grafted light chains comprise donor residues at at least one of positions (1) and/or (3) and (46) and/or (47) or at at least one of positons (46, 48, 58) and (71), The CDR-grafted antibodies are preferably humanised antibodies, having non human, eg. rodent, donor and human acceptor frameworks, and may be used for in vivo therapy and diagnosis. A generall applicable protocol is disclosed for obtaining CDR-grafted antibodies.

Abstract: CDR-grafted antibody heavy and light chains comprise acceptor framework and donor antigen binding regions, the heavy chains comprising donor residues at at least one of positions (6, 23) and/or (24, 48) and/or (49, 71) and/or (73, 75) and/or (76) and/or (78) and (88) and/or (91). The CDR-grafted light chains comprise donor residues at at least one of positions (1) and/or (3) and (46) and/or (47) or at at least one of positions (46,48, 58) and (71). The CDR-grafted antibodies arc preferably humanised antibodies, having non human, e.g. rodent, donor and human acceptor frameworks, and may be used for in vivo therapy and diagnosis.

Abstract: CDR-grafted antibody heavy and light chains comprise acceptor framework and donor antigen binding regions, the heavy chains comprising donor residues at at least one of positions (6, 23) and/or (24, 48) and/or (49, 71) and/or (73, 75) and/or (76) and/or (78) and (88) and/or (91). The CDR-grafted light chains comprise donor residues at at least one of positions (1) and/or (3) and (46) and/or (47) or at at least one of positions (46, 48, 58) and (71). The CDR-grafted antibodies are preferably humanised antibodies, having non human, eg. rodent, donor and human acceptor frameworks, and may be used for in vivo therapy and diagnosis. A generally applicable protocol is disclosed for obtaining CDR-grafted antibodies.

Abstract: CDR-grafted antibody heavy and light chains comprise acceptor framework and donor antigen binding regions, the heavy chains comprising donor residues at at least one of positions (6, 23) and/or (24, 48) and/or (49, 71) and/or (73, 75) and/or (76) and/or (78) and (88) and/or (91). The CDR-grafted light chains comprise donor residues at at least one of positions (1) and/or (3) and (46) and/or (47) or at at least one of positions (46, 48, 58) and (71). The CDR-grafted antibodies are preferably humanised antibodies, having non human, e.g. rodent, donor and human acceptor frameworks, and may be used for in vivo therapy and diagnosis. A generally applicable protocol is disclosed for obtaining CDR-grafted antibodies.

Abstract: CDR-grafted antibody heavy and light chains comprise acceptor framework and donor antigen binding regions, the heavy chains comprising donor residues at at least one of positions (6, 23) and/or (24, 48) and/or (49, 71) and/or (73, 75) and/or (76) and/or (78) and (88) and/or (91). The CDR-grafted light chains comprise donor residues at at least one of positions (1) and/or (3) and (46) and/or (47) or at at least one of positions (46,48, 58) and (71). The CDR-grafted antibodies are preferably humanised antibodies, having non human, e.g. rodent, donor and human acceptor frameworks, and may be used for in vivo therapy and diagnosis. A generally applicable protocol is disclosed for obtaining CDR-grafted antibodies.

Abstract: The present invention provides a method and an apparatus for tuning the phase shifting of a phase shift mask having an attenuating phase shifting material providing at least 160.degree. of phase shift. The method comprising the utilization of a phase measurement and selective etching operations which reduces the challenge of making an exacting 180.degree. phase shifting mask. An attenuated phase shift mask structure is also disclosed in the present invention.

Abstract: The present invention provides a method and an apparatus for tuning the phase shifting of a phase shift mask having an attenuating phase shifting material providing at least 160.degree. of phase shift. The method comprising the utilization of a phase measurement and selective etching operations which reduces the challenge of making an exacting 180.degree. phase shifting mask. An attenuated phase shift mask structure is also disclosed in the present invention.